{
    "id": 28003,
    "fullName": "GPBP1 dec exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "GPBP1 dec exp indicates decreased expression of the Gpbp1 protein and/or mRNA. However, the mechanism causing the decreased expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 65056,
        "geneSymbol": "GPBP1",
        "terms": [
            "GPBP1",
            "GPBP",
            "SSH6",
            "VASCULIN"
        ]
    },
    "variant": "dec exp",
    "createDate": "05/01/2018",
    "updateDate": "05/01/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 13830,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, human mammary epithelial cells with knockdown of GPBP1 and expressing a BRCA1 mutation demonstrated resistance to Talazoparib (BMN673) treatment in culture (PMID: 29669295).",
            "molecularProfile": {
                "id": 29576,
                "profileName": "BRCA1 mut GPBP1 dec exp"
            },
            "therapy": {
                "id": 682,
                "therapyName": "Talazoparib",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 11296,
                    "pubMedId": 29669295,
                    "title": "A Quantitative Chemotherapy Genetic Interaction Map Reveals Factors Associated with PARP Inhibitor Resistance.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29669295"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 29574,
            "profileName": "GPBP1 dec exp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 29575,
            "profileName": "BRCA1 dec exp GPBP1 dec exp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 29576,
            "profileName": "BRCA1 mut GPBP1 dec exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}